Supplemental material
OncoImmunology
Volume 11, 2022 - Issue 1
Original Research
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
, , , 
, , , & show all
André Stevena Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germanyhttps://orcid.org/0000-0003-4860-3399View further author information
https://orcid.org/0000-0003-4860-3399View further author information, Daniel Bethmannb Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germanyhttps://orcid.org/0000-0002-9582-025XView further author information
https://orcid.org/0000-0002-9582-025XView further author information, , Claudia Wickenhauserb Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germanyhttps://orcid.org/0000-0002-1807-5575View further author information
https://orcid.org/0000-0002-1807-5575View further author information & Barbara Seligera Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany;c Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, GermanyCorrespondence[email protected]
https://orcid.org/0000-0002-5544-4958View further author information
https://orcid.org/0000-0002-5544-4958View further author information show all